36.9 F
Monday, December 6, 2021

    Latest Posts

    Anxiety about insomnia meds is keeping woman awake

    Dear Dr. Roach: I am a 77-year-old woman. I have had problems with insomnia for at least 50 years, but it is much worse now. Some nights I don’t sleep, and some nights I get maybe three or four hours. My primary doctor will prescribe only certain meds and will not prescribe meds I took in the past, like Dalmane or others. All he will prescribe is Lunesta or Ambien, and lorazepam when needed. I do take melatonin 5 mg. I am at my wits’ end. I have OCD about insomnia — I worry what will happen to me with all of this sleep loss. My doctor says I am relatively healthy, with normal blood pressure and recent blood tests. Should I see a psychiatrist? Maybe they can find some med that would work.

    — Anon.

    Dear Anon.: Insomnia is a common problem, and while medication treatment can be useful, medications should not be the first line of treatment. Most people with insomnia do well with behavioral changes. Hopefully, you have made some of these changes over 50 years of having insomnia.

    When people don’t have success with sleep hygiene, then sometimes medications are used. I am a bit concerned about the three different classes of sleep aids you are taking. Eszopiclone (Lunesta) and zolpidem (Ambien) work on a receptor in the brain called the GABA receptor, which is the same receptor that the benzodiazepines lorazepam (Ativan) and flurazepam (Dalmane) affect. Dalmane is seldom used anymore for sleep, because it is converted by the liver a metabolite, which can last for days. Long-term use of benzodiazepines has the potential for development of withdrawal symptoms even while taking the same dose. I avoid prescribing them long term. They also increase the risk of falls, and of driving accidents for people who drive. Melatonin works on its own, separate receptor, and is much safer.

    Source link

    Latest Posts


    Don't Miss

    Stay in touch

    To be updated with all the latest news, offers and special announcements.